Valeant Pharmaceuticals Intl's (VRX) "Hold" Rating Reaffirmed at Mizuho


's stock had its "hold" rating reaffirmed by analysts at Mizuho in a research report issued on Sunday, Market Beat reports. An institutional investor recently raised its position in Valeant Pharmaceuticals Intl stock.



from Biotech News